Insight

Krishan Jethwa: German Rectal Cancer Study Group informs prognostic significance of ypN+ after nCRT

mayoclinic.org

Nov 3, 2024, 15:29

Krishan Jethwa: German Rectal Cancer Study Group informs prognostic significance of ypN+ after nCRT

Krishan Jethwa, GI Radiation Oncologist at Mayo Clinic, shared a post on X about a recent paper by Markus Diefenhardt et al. published in JAMA Network Open.

“German Rectal Cancer Study Group informs prognostic significance of ypN+ after nCRT

ypN+ (ypN2) associated with:

High DM
High Locoregional recurrence
Low OS

Trials needed to explore post-op intensification? How to integrate with other biomarkers (eg ctDNA)?”

“Persistent Lymph Node Metastases After Neoadjuvant Chemoradiotherapy for Rectal Cancer”

Authors: Markus Diefenhardt, Daniel Martin, Ralf-Dieter Hofheinz, Michael Ghadimi, Emmanouil Fokas, Claus Rödel, Maximilian Fleischmann.

Krishan Jethwa: German Rectal Cancer Study Group informs prognostic significance of ypN+ after nCRT

More posts featuring Krishan Jethwa.

cancer Claus Rödel Daniel Martin Emmanouil Fokas Krishan Jethwa Markus Diefenhardt Maximilian Fleischmann Mayo Clinic Michael Ghadimi OncoDaily Oncology Ralf-Dieter Hofheinz

Carlos Rodriguez-Galindo: The Man Who Will Cure the World

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Special Coverage